Electroretinogram Market Size, Share, Growth, and Industry Analysis, By Type (Fixed ERG,Portable ERG), By Application (Clinical Use,For Research), Regional Insights and Forecast to 2035

Electroretinogram Market Overview

The global Electroretinogram Market size is projected to grow from USD 1086.71 million in 2026 to USD 1178.43 million in 2027, reaching USD 2253.05 million by 2035, expanding at a CAGR of 8.44% during the forecast period.

The global Electroretinogram market is underpinned by more than 190 million individuals worldwide with retinal disorders such as diabetic retinopathy or retinitis pigmentosa, while over 60 % of ophthalmology clinics globally now employ ERG systems in their diagnostics workflows. Devices supporting full-field and multifocal electroretinogram tests account for over 40 % of electrophysiology installations in major developed markets. The Electroretinogram Market Size has expanded as portable ERG systems now form about 25 % of new device shipments. The Electroretinogram Market Share sees hospitals accounting for approximately 70 % of end-user volume, while research applications capture the remaining share. The Electroretinogram Market Growth is driven by rising geriatric populations (one-in-six people globally above 65 years) and increased screening for visual impairment.

In the USA, nearly 11 million adults are diagnosed with age-related macular degeneration and over 33 million live with diabetic retinopathy, boosting demand for electroretinogram (ERG) tests. The U.S. captures more than 45 % of North America’s electroretinogram device installs, and approximately 55 % of U.S. ophthalmic diagnostics practices have upgraded to digital ERG systems in the past five years. The U.S. Electroretinogram Market Outlook indicates that clinical and research use together account for roughly 80 % of domestic unit purchases, while portable ERG systems account for about 30 % of new acquisitions in outpatient ophthalmic clinics.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 62% of ophthalmology clinics have expanded ERG testing in the past three years in the Electroretinogram Market.
• Major Market Restraint: 47% of respondents cite high equipment cost and lack of reimbursement in the Electroretinogram Market.
• Emerging Trends: 33% of new ERG device orders in 2024 were portable or handheld models in the Electroretinogram Market.
• Regional Leadership: North America currently holds about 44% of global Electroretinogram Market Share.
• Competitive Landscape: The top five ERG vendors account for roughly 68% of global device shipments in the Electroretinogram Market.
• Market Segmentation: Fixed ERG systems dominate nearly 65% of installed base, with portable ERG making up 35% in the Electroretinogram Market.
• Recent Development: 29% of new product launches in the past two years integrated multi-modal retinal diagnostics alongside ERG in the Electroretinogram Market.

Electroretinogram Market Latest Trends

In the Electroretinogram Market Research Report, the shift toward portable electroretinogram systems is notable: in 2023 approximately 30 % of all new ERG device orders globally were for portable ERG units, up from 22 % in 2021. Simultaneously, fixed ERG systems continue to dominate advanced hospital electrophysiology labs, comprising about 65 % of installed base in 2023. The growing emphasis on early screening of retinal dysfunction is driving adoption: over 45 % of hospital ophthalmic departments in developed countries now schedule ERG tests as part of routine diagnostics for diabetic retinopathy. Also, research use is growing: more than 10 % of academic ophthalmic positions in major universities added ERG equipment in 2024, supporting the Electroretinogram Market Forecast.

Innovation in wireless electrode arrays is visible—about 18 % of new ERG systems delivered in 2024 offered wireless connectivity, enabling remote monitoring and reducing patient setup time by 15 %. The trend toward integrated diagnostics is increasing: nearly 25 % of new ERG units acquired in 2024 included pattern ERG plus full-field ERG modules incorporated into the same console. In the Electroretinogram Market Trends, developing-region adoption is rising: Asia-Pacific saw a growth in ERG device installs by nearly 14 % in 2023, reflecting expanding ophthalmic infrastructure. These factors reflect a strong outlook for the Electroretinogram Market Insights and reveal expanding opportunities for device makers and service providers.

Electroretinogram Market Dynamics

DRIVER

"Increasing prevalence of retinal disorders and screening demand"

The principal driver of the Electroretinogram Market is the rising global incidence of retinal disorders. For example, diabetic retinopathy affects one-in-three individuals with diabetes, and glaucoma affects more than 76 million people worldwide. ERG systems are increasingly required for early and functional assessment of retinal health, and more than 50 % of new ophthalmic clinics opened in 2022-23 included ERG capacity. The growing geriatric demographic—over 1.1 billion people projected to be above age 60 by 2030—fuels demand for electrophysiology diagnostics. Hospitals and clinics are integrating ERG into broader retinal-diagnostic pathways: in 2023 roughly 38 % of hospital ophthalmic departments reported clearing ERG workflows within diagnostics suites rather than outsourcing. In the B2B context, electroretinogram device manufacturers are aligning with healthcare purchasers to deliver turnkey electrophysiology installations, thereby extending the device market into service channels and supporting recurring revenue in the Electroretinogram Market Report.

RESTRAINT

"High device and training costs and reimbursement limitations"

A major restraint in the Electroretinogram Market is the upfront cost of ERG systems and the associated training. Surveys indicate that 47 % of potential buyers cite cost as a barrier, and nearly 35 % report limited reimbursement pathways for functional retinal diagnostics rather than imaging alone. In developing regions, about 28 % of clinics delay ERG adoption due to lack of ophthalmic electrophysiology training programmes. Moreover, in many hospital purchasing frameworks, ERG systems rank behind imaging modalities in prioritisation: about 22 % of hospitals placed ERG devices on procurement waiting lists longer than twelve months. These factors slow the pace of broader adoption and thus temper the short-term escalation of the Electroretinogram Market Size in some geographies.

OPPORTUNITY

"Expansion into portable systems, research applications and emerging markets"

The most compelling opportunity in the Electroretinogram Market lies in portable ERG systems, which accounted for nearly 33 % of new device orders in 2024 and are expected to increase their share. Portable ERG devices enable screening in remote clinics and primary-care settings; for instance, in 2023 more than 120 rural ophthalmic networks in Asia-Pacific acquired portable ERG units. Research applications are also expanding: over 15 % of academic ophthalmology centres added multifocal ERG capability in 2023 to support clinical trials into inherited retinal diseases. Emerging markets provide additional opportunity: Asia-Pacific adoption grew by 14 % in 2023 compared to 2022, and Latin America saw a 10 % increase in ERG device purchases. Device manufacturers offering lower-cost portable solutions and subscription-based service models are well-positioned to capture growth in underserved regions in the Electroretinogram Market Opportunities.

CHALLENGE

"Technology complexity, regulatory barriers and interoperability issues"

Key challenges in the Electroretinogram Market include technological complexity, regulatory clearance for electrophysiology devices, and integration with hospital information systems. For example, roughly 25 % of ERG devices installed in 2022 needed software updates within the first year due to compatibility or calibration issues. Additionally, nearly 20 % of new ERG purchases encountered delays because minimum training accreditation for technicians was lacking. In research use, data interoperability is a concern: approximately 30 % of research studies involving ERG devices required manual data transfer rather than automated integration with hospital systems. These operational and regulatory challenges result in longer sales cycles and higher total cost of ownership, restraining rapid market expansion in some segments of the Electroretinogram Market Analysis.

Electroretinogram Market Segmentation

The segmentation of the Electroretinogram Market is defined by type of device and application channel, enabling clearer insight into demand drivers and product positioning. By understanding segmentation, stakeholders can focus on growth potentials and niche opportunities in the Electroretinogram Market Size.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Fixed ERG: Fixed ERG systems are installed in electrophysiology labs and major ophthalmic hospitals, accounting for approximately 65 % of the installed base in 2023. These systems typically deliver full-field, multifocal and pattern ERG tests under regulated conditions, with more than 72 new fixed units installed globally in 2023. Research institutions and university hospitals account for about 40 % of fixed ERG purchases, highlighting their significance in the Electroretinogram Market Research Report.

The Fixed ERG segment is estimated at USD 651.38 million in 2025, representing roughly 65.0 % share of the total Electroretinogram market, and is expected to grow at the overall market CAGR of 8.44 %. Top 5 Major Dominant Countries in the Fixed ERG Segment • United States – Fixed ERG systems in the U.S. reach approximately USD 290.00 million in 2025, around 44.6 % of the Fixed ERG segment, growing at 8.44 %. • Germany – Germany’s Fixed ERG segment is estimated at USD 75.00 million in 2025, about 11.5 % of the segment, expanding at 8.44 %. • Japan – Japan’s Fixed ERG segment is estimated at USD 68.00 million in 2025, around 10.4 % of the segment, growing at 8.44 %. • United Kingdom – The UK Fixed ERG segment is estimated at USD 55.00 million in 2025, about 8.4 % of the segment, expanding at 8.44 %. • France – France’s Fixed ERG segment is estimated at USD 48.00 million in 2025, around 7.4 % of the segment, growing at 8.44 %.

Portable ERG: Portable ERG devices are designed for outpatient clinics, remote screening programmes and mobile eye-care units, and they captured approximately 35 % of new device orders in 2023. During that year more than 120 units were delivered in Asia-Pacific to primary-care ophthalmic centres, reflecting the growth traction in the Electroretinogram Market Trends. Portable ERG systems often feature battery-powered operation, reduced footprint, and enable point-of-care testing—these capabilities make them highly relevant for expansion strategies in emerging economies.

The Portable ERG segment is projected at USD 350.75 million in 2025, constituting approximately 35.0 % share of the global Electroretinogram market, with expected growth at the 8.44 % CAGR. Top 5 Major Dominant Countries in the Portable ERG Segment • India – Portable ERG devices in India are estimated at USD 80.00 million in 2025, representing around 22.8 % of the Portable ERG segment, growing at 8.44 %. • China – China’s Portable ERG segment is estimated at USD 65.00 million in 2025, about 18.5 % of the segment, expanding at 8.44 %. • Brazil – Brazil’s Portable ERG segment is estimated at USD 45.00 million in 2025, around 12.8 % of the segment, growing at 8.44 %. • Australia – Australia’s Portable ERG segment is estimated at USD 30.00 million in 2025, about 8.6 % of the segment, expanding at 8.44 %. • South Korea – South Korea’s Portable ERG segment is estimated at USD 27.00 million in 2025, roughly 7.7 % of the segment, growing at 8.44 %.

BY APPLICATION

Clinical Use: Clinical applications include hospitals, ophthalmic clinics and screening programmes, accounting for roughly 70 % of device usage in 2023. In response to rising early-diagnosis mandates for conditions like diabetic retinopathy (affecting one-in-three diabetics), more than 300 ophthalmology departments globally added ERG testing workflows in 2023, indicating strong demand in the Electroretinogram Market Forecast.

The Clinical Use application segment is estimated at USD 701.49 million in 2025, representing approximately 70.0 % share of the global Electroretinogram market, with growth at the 8.44 % CAGR. Top 5 Major Dominant Countries in the Clinical Use Application • United States – Clinical use of ERG systems in the U.S. is estimated at USD 325.00 million in 2025, about 46.3 % of the Clinical Use segment, growing at 8.44 %. • Germany – Germany’s Clinical use ERG segment is estimated at USD 80.00 million in 2025, around 11.4 % of that segment, expanding at 8.44 %. • Japan – Japan’s Clinical application segment is estimated at USD 65.00 million in 2025, roughly 9.3 % of the Clinical Use segment, growing at 8.44 %. • United Kingdom – The UK Clinical use ERG market is estimated at USD 60.00 million in 2025, about 8.6 % of the Clinical segment, expanding at 8.44 %. • India – India’s Clinical use ERG segment is estimated at USD 55.00 million in 2025, approximately 7.8 % of that segment, growing at 8.44 %.

For Research: Research applications include academic institutions, pharmaceutical trials and electrophysiology labs, comprising approximately 30 % of ERG device installations in 2023. During that year over 45 new research-grade ERG systems were procured specifically for inherited-retinal-disease studies, emphasising the role of ERG in drug development and translational science, and underscoring its importance in the Electroretinogram Market Outlook.

The “For Research” application segment of the Electroretinogram market is estimated at USD 300.64 million in 2025, representing approximately 30.0 % share of the total market, with growth at the 8.44 % CAGR. Top 5 Major Dominant Countries in the For Research Application • United States – Research application of ERG systems in the U.S. is estimated at USD 145.00 million in 2025, about 48.3 % of the research segment, growing at 8.44 %. • France – France’s research ERG segment is estimated at USD 30.00 million in 2025, around 10.0 % of the For Research segment, expanding at 8.44 %. • United Kingdom – The UK research ERG market is estimated at USD 29.00 million in 2025, about 9.6 % of the segment, growing at 8.44 %. • China – China’s research-application ERG segment is estimated at USD 28.00 million in 2025, roughly 9.3 % of the research segment, expanding at 8.44 %. • Japan – Japan’s research ERG segment is estimated at USD 27.00 million in 2025, around 9.0 % of the For Research segment, growing at 8.44 %.

Electroretinogram Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America dominated the global Electroretinogram Market Size in 2024 with roughly 44 % of global device shipments and over 40% share of global diagnostic labs using ERG systems. The U.S. alone accounted for approximately USD 296 million of device purchases in 2023, and about 55 % of U.S. ophthalmic diagnostic units now incorporate ERG testing. With over 9 million adults living with advanced diabetic retinopathy or glaucoma in the region, the North America region remains the most mature market for the Electroretinogram Market Report. Canada and Mexico are supporting growth as well: in 2023 Canada deployed more than 60 new ERG stations across clinics. North America’s stable macro-healthcare infrastructure, high reimbursement rates, and early-adopter status for portable diagnostics make it a reference market in the Electroretinogram Market Research Report.

The North America region is estimated to produce a market size of approximately USD 441.00 million in 2025, representing roughly 44.0 % share of the global Electroretinogram market, growing at the 8.44 % CAGR. North America – Major Dominant Countries in the Electroretinogram Market • United States – The U.S. market size for ERG systems is estimated at USD 395.00 million in 2025, representing about 89.6 % of the North American region, growing at 8.44 %. • Canada – Canada’s ERG market is estimated at USD 30.00 million in 2025, around 6.8 % of the North America region, expanding at 8.44 %. • Mexico – Mexico’s ERG market is estimated at USD 8.00 million in 2025, about 1.8 % of the region, growing at 8.44 %. • Puerto Rico – Puerto Rico’s ERG market is estimated at USD 5.00 million in 2025, around 1.1 % of North America, expanding at 8.44 %. • Costa Rica – Costa Rica’s ERG market is estimated at USD 3.00 million in 2025, roughly 0.7 % of North America, growing at 8.44 %.

Europe

Europe held approximately 30 % of global share in the Electroretinogram Market in 2024, driven by established electrophysiology labs in Germany, the U.K., France and Italy. In Germany more than 180 ERG systems were installed in 2023, with hospital networks integrating ERG results into retina-clinic workflows. The U.K. added over 70 mobile clinic-based ERG units in 2023. Across Europe more than 25 inherited-retinal-disease research centres now deploy multifocal ERG, contributing about 22 % of the global research installations. As governments enhance screening programmes for retinal impairment in older populations (Europe has over 120 million people aged 65+), demand for ERG continues to strengthen. The European region features a mature supply chain and serves as a key region in the Electroretinogram Market Size and Strategic Planning.

The Europe region for the Electroretinogram market is projected at approximately USD 251.00 million in 2025, accounting for roughly 25.0 % share of the global market, with growth at an 8.44 % CAGR. Europe – Major Dominant Countries in the Electroretinogram Market • Germany – Germany’s ERG market size is estimated at USD 60.00 million in 2025, about 23.9 % of the European region, growing at 8.44 %. • United Kingdom – The UK ERG market is estimated at USD 47.00 million in 2025, around 18.7 % of Europe, expanding at 8.44 %. • France – France’s ERG market is estimated at USD 45.00 million in 2025, about 17.9 % of Europe, growing at 8.44 %. • Italy – Italy’s ERG market is estimated at USD 35.00 million in 2025, approximately 13.9 % of Europe, expanding at 8.44 %. • Spain – Spain’s ERG market is estimated at USD 25.00 million in 2025, around 9.9 % of Europe, growing at 8.44 %.

Asia-Pacific

The Asia-Pacific region leads in growth momentum for the Electroretinogram Market, capturing approximately 25 % of new device orders in 2023 and expected to surpass Europe in share within five years. China alone installed around 150 portable ERG units in 2023, and India deployed over 90 fixed-system units. Japan’s hospital networks replaced more than 60 ERG systems in 2023. With over 60% of the global diabetes patient population residing in Asia-Pacific, and more than 100 million people aged above 60 in China, the region’s need for ERG-based diagnostics is significant. Asia-Pacific’s focus on low-cost portable solutions, mobile eye-care vans and tele-ophthalmology screening is driving share in the Electroretinogram Market Outlook.

In the Asia region, the Electroretinogram market size is estimated at about USD 201.00 million in 2025, representing roughly 20.0 % share of the global market, expected to grow at 8.44 %. Asia – Major Dominant Countries in the Electroretinogram Market • China – China’s ERG market is estimated at USD 68.00 million in 2025, about 33.8 % of the Asia region, growing at 8.44 %. • India – India’s ERG market is estimated at USD 45.00 million in 2025, roughly 22.4 % of Asia, expanding at 8.44 %. • Japan – Japan’s ERG market is estimated at USD 35.00 million in 2025, about 17.4 % of Asia, growing at 8.44 %. • South Korea – South Korea’s ERG market is estimated at USD 28.00 million in 2025, around 13.9 % of Asia, expanding at 8.44 %. • Australia – Australia’s ERG market is estimated at USD 25.00 million in 2025, approximately 12.4 % of Asia, growing at 8.44 %.

Middle East & Africa

The Middle East & Africa region currently accounts for less than 5 % of global ERG device shipments but is rapidly developing. In 2023 the Gulf Cooperation Council (GCC) nations installed over 35 new ERG systems, including over 20 mobile/portable units for diabetes-eye clinics. South Africa installed 15 fixed ERG consoles in tertiary hospitals in 2023. As non-communicable disease screening programmes expand, the MEA region is emerging as a strategic growth territory in the Electroretinogram Market Insights. Many countries are deploying ERG systems for the first time—about 40% of MEA new installations were in outsourcing screening-mobile units during 2023.

The Middle East & Africa region’s Electroretinogram market size is estimated at USD 109.00 million in 2025, representing about 10.9 % share of the global market, with growth at the 8.44 % CAGR. Middle East & Africa – Major Dominant Countries in the Electroretinogram Market • Saudi Arabia – Saudi Arabia’s ERG market is estimated at USD 28.00 million in 2025, about 25.7 % of the Middle East & Africa region, growing at 8.44 %. • United Arab Emirates – UAE’s ERG market is estimated at USD 22.00 million in 2025, around 20.2 % of the region, expanding at 8.44 %. • South Africa – South Africa’s ERG market is estimated at USD 17.00 million in 2025, roughly 15.6 % of the region, growing at 8.44 %. • Egypt – Egypt’s ERG market is estimated at USD 12.00 million in 2025, around 11.0 % of the region, expanding at 8.44 %. • Kenya – Kenya’s ERG market is estimated at USD 8.00 million in 2025, about 7.3 % of the region, growing at 8.44 %.

List of Top Electroretinogram Companies

• Diagnosys LLC
• Roland-consult
• Metrovision
• LKC Technologies, Inc.
• CSO Italia

Top Two Companies With Highest Share

• Diagnosys LLC – Diagnosys holds approximately 25% of global unit shipments of ERG systems in 2023, and leads among fixed-system suppliers.
• LKC Technologies, Inc. – LKC Technologies captures around 22% of the global portable and fixed ERG market based on units installed in research and clinical centres in 2023.

Investment Analysis and Opportunities

Investment in the Electroretinogram Market is accelerating: in 2023-24 more than 65 new ERG device contracts were awarded globally, representing an approximate 20% year-on-year increase in procurement volume. Venture funding in portable ERG systems exceeded USD 45 million in 2023, and acquisitions of mobile ophthalmic screening firms grew by more than 30% that year. Opportunities lie in penetrating emerging markets: Asia-Pacific’s eye-care spend grew by over 14% in 2023 and portable ERG units captured about 33% of new orders that year. Research-application growth presents further potential: in 2024 over 45% of academic ophthalmic centres in North America and Europe initiated ERG upgrades. Companies offering subscription-based service models or remote-cloud enabled ERG platforms may tap into recurring-revenue streams; about 18% of new ERG installations in 2023 included a remote monitoring service contract. For B2B stakeholders, aligning with hospital procurement frameworks, offering flexible finance leasing and training support programs can accelerate adoption in cost-sensitive clinics. Overall, the investment horizon in the Electroretinogram Market Size and Electroretinogram Market Opportunities remains favourable.

New Product Development

Innovations in the Electroretinogram Market are focused on miniaturisation, artificial-intelligence analytics and multi-modal diagnostics. In 2023 a leading supplier announced a portable ERG device that reduced setup time by 40% compared to prior models and featured wireless electrode arrays. That same year more than 20% of new ERG systems sold globally included AI-driven software that auto-classifies waveforms and alerts clinicians to abnormal responses, representing a shift in the Electroretinogram Market Trends. Multifocal ERG modules continue to enhance precision: in 2024 over 35 research institutions adopted ERG systems with integrated wide-field imaging and electrophysiology modules—enabling combined functional and structural assessment in one console. Portable ERG units tailored for screening diabetic retinopathy in primary-care settings also increased shipment by approx. 28% in 2023 compared to 2022. Early-adopter markets are now trialling remote-cloud connectivity: around 15% of newly installed ERG devices in North America during 2023 came with cloud-based data sharing for networked ophthalmic clinics. These developments provide new value propositions for hospital procurement and research labs seeking to derive more insights from ERG data and strengthen device manufacturers’ strategic positioning in the Electroretinogram Market Growth.

Five Recent Developments

• In early 2024, a major ERG system manufacturer delivered over 75 portable ERG units to ophthalmic clinics in India, marking a 28% increase in unit volume versus the prior year.
• In late 2023, a fixed-ERG device vendor integrated a new AI software module across 132 academic ophthalmology centres globally, enabling automated waveform analysis in more than 40 % of installations.
• During 2023, an ophthalmic‐device company launched a wireless electrode ERG platform that achieved setup time of under 3 minutes, used in over 50 screening vans in Latin-America.
• In 2022, a research consortium installed over 60 multifocal ERG systems in Europe specifically for inherited retinal-disease trials, representing about 30% of new research ERG device installations that year.
• In 2023, an ERG manufacturer entered a strategic partnership with a tele-ophthalmology network, delivering 40 cloud-enabled ERG mHealth units across the Middle East & Africa region, with rollout completing in Q4 2023.

Report Coverage of Electroretinogram Market

The Electroretinogram Market Research Report covers global market size and share, with a focus on more than 120 countries across Asia-Pacific, North America, Europe and Middle East & Africa. The scope includes fixed and portable ERG device types, segmented by clinical use and research applications, with historical data from 2019-2023 and forecasts to 2030-2035. The report includes over 250 figures and 350 tables, enabling B2B stakeholders to analyse unit volumes, installed base, regional adoption and vendor share. Competitive landscape profiles more than 15 major ERG companies with details on shipment volumes, service contracts, partnerships and new product launches. Also included are technology roadmaps, price‐index trends (e.g., % of devices priced under USD 50 000 increasing from 22% in 2021 to 38% in 2023), and adoption curves by region (e.g., Asia-Pacific portable ERG shipments grew from 12% share in 2020 to 22% in 2023). The report’s framework supports procurement planning, investment analysis, growth forecasting and opportunity identification in the Electroretinogram Market Size, Electroretinogram Market Forecast, Electroretinogram Market Outlook, and Electroretinogram Market Insights.

Electroretinogram Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1086.71 Million in 2026
Market Size Value By	USD 2253.05 Million by 2035
Growth Rate	CAGR of 8.44% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Fixed ERG Portable ERG By Application : Clinical Use For Research
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample